Lim SY - Search Results

1

Necrostatin: a potentially novel cardioprotective agent?

Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM. Smith CC, et al. Among authors: lim sy. Cardiovasc Drugs Ther. 2007 Aug;21(4):227-33. doi: 10.1007/s10557-007-6035-1. Epub 2007 Jul 31. Cardiovasc Drugs Ther. 2007. PMID: 17665295

2

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Mocanu MM, Yellon DM, Smith CC. Lim SY, et al. Cardiovasc Drugs Ther. 2007 Dec;21(6):467-9. doi: 10.1007/s10557-007-6067-6. Cardiovasc Drugs Ther. 2007. PMID: 17965927 Free PMC article.

3

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Lim SY, et al. Cardiovasc Res. 2007 Aug 1;75(3):530-5. doi: 10.1016/j.cardiores.2007.04.022. Epub 2007 May 4. Cardiovasc Res. 2007. PMID: 17512507 Free PMC article.

4

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Simpkin JC, et al. Among authors: lim sy. Basic Res Cardiol. 2007 Nov;102(6):518-28. doi: 10.1007/s00395-007-0671-2. Epub 2007 Aug 13. Basic Res Cardiol. 2007. PMID: 17694254

5

The novel adipocytokine visfatin exerts direct cardioprotective effects.

Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM, Hausenloy DJ. Lim SY, et al. J Cell Mol Med. 2008 Aug;12(4):1395-403. doi: 10.1111/j.1582-4934.2008.00332.x. Epub 2008 Apr 8. J Cell Mol Med. 2008. PMID: 18400051 Free PMC article.

6

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

Lim SY, Davidson SM, Yellon DM, Smith CC. Lim SY, et al. Basic Res Cardiol. 2009 Nov;104(6):781-92. doi: 10.1007/s00395-009-0034-2. Epub 2009 May 22. Basic Res Cardiol. 2009. PMID: 19462153

7

Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.

Hausenloy DJ, Lim SY, Ong SG, Davidson SM, Yellon DM. Hausenloy DJ, et al. Among authors: lim sy. Cardiovasc Res. 2010 Oct 1;88(1):67-74. doi: 10.1093/cvr/cvq113. Epub 2010 Apr 16. Cardiovasc Res. 2010. PMID: 20400621 Free PMC article.

8

Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.

Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Ong SB, et al. Among authors: lim sy. Circulation. 2010 May 11;121(18):2012-22. doi: 10.1161/CIRCULATIONAHA.109.906610. Epub 2010 Apr 26. Circulation. 2010. PMID: 20421521

9

Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury.

Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ, Yellon DM. Smith CC, et al. Among authors: lim sy. J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):63-71. doi: 10.1177/1074248410382232. Epub 2010 Dec 23. J Cardiovasc Pharmacol Ther. 2011. PMID: 21183727

10

HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.

Ong SG, Lee WH, Theodorou L, Kodo K, Lim SY, Shukla DH, Briston T, Kiriakidis S, Ashcroft M, Davidson SM, Maxwell PH, Yellon DM, Hausenloy DJ. Ong SG, et al. Among authors: lim sy. Cardiovasc Res. 2014 Oct 1;104(1):24-36. doi: 10.1093/cvr/cvu172. Epub 2014 Jul 25. Cardiovasc Res. 2014. PMID: 25063991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,482 results

Search Page

Filters